We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Vectura has confirmed that it has won the US GlaxoSmithKline (GSK) patent litigation trial and has been awarded $89.7million in damages by the trial jury.